Behind the Curve: Late-Onset Axial Spondyloarthritis

Published:October 03, 2018DOI:
      The patient's diagnosis was more commonly associated with people in their teens and twenties. Yet, a 56-year-old woman met the criteria. Her primary care physician referred her to us after a 3-month history of neck and low back pain. The pain was sharp in nature, started from the posterior neck, and gradually involved the rest of the back. It persisted throughout the day and was worse with physical activity. She had associated morning stiffness, typically lasting 30 minutes to 1 hour. This was accompanied by generalized lethargy, poor appetite, and an unintentional weight loss of 2 kg (from 48 to 46 kg) over the same 3-month period. She had no weakness, numbness, night pain, fever, or night sweats and no history of trauma or falls. Despite her discomfort, she was still able to work and had some pain relief with oral acetaminophen. She had no significant prior medical history.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rudwaleit M
        • van der Heijde D
        • Landewé R
        • et al.
        The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
        Ann Rheum Dis. 2009; 68: 777-783
        • Feldtkeller E
        • Khan MA
        • van der Heijde D
        • van der Linden S
        • Braun J
        Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis.
        Rheumatol Int. 2003; 23: 61-66
        • Toussirot E.
        Late-onset ankylosing spondylitis and spondylarthritis: an update on clinical manifestations, differential diagnosis, and pharmacological therapies.
        Drugs Aging. 2010; 27: 523-531
        • Sieper J
        • van der Heijde
        • Landewé R
        • et al.
        New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).
        Ann Rheum Dis. 2009; 68: 784-788
        • Kroon F
        • Landewé R
        • Dougados M
        • van der Heijde D
        Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis.
        Ann Rheum Dis. 2012; 71: 1623-1629
        • Fleischmann R
        • Baumgartner SW
        • Weisman MH
        • Liu T
        • White B
        • Peloso P
        Long term safety of etanercept in elderly subjects with rheumatic diseases.
        Ann Rheum Dis. 2006; 65: 379-384
        • Chen J
        • Lin S
        • Liu C
        Sulfasalazine for ankylosing spondylitis.
        Cochrane Database Syst Rev. 2014 Nov 27; CD004800